75 related articles for article (PubMed ID: 21241714)
21. Role of Nuclear Factor Erythroid 2-Related Factor 2 in Diabetic Nephropathy.
Cui W; Min X; Xu X; Du B; Luo P
J Diabetes Res; 2017; 2017():3797802. PubMed ID: 28512642
[TBL] [Abstract][Full Text] [Related]
22. Prevention of Streptozotocin-Induced Diabetic Nephropathy by MG132: Possible Roles of Nrf2 and I
Kong L; Wang Y; Luo M; Tan Y; Cui W; Miao L
Oxid Med Cell Longev; 2017; 2017():3671751. PubMed ID: 28373900
[TBL] [Abstract][Full Text] [Related]
23. Zinc Prevents the Development of Diabetic Cardiomyopathy in db/db Mice.
Wang S; Wang B; Wang Y; Tong Q; Liu Q; Sun J; Zheng Y; Cai L
Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28272348
[TBL] [Abstract][Full Text] [Related]
24. Metallothionein Is Downstream of Nrf2 and Partially Mediates Sulforaphane Prevention of Diabetic Cardiomyopathy.
Gu J; Cheng Y; Wu H; Kong L; Wang S; Xu Z; Zhang Z; Tan Y; Keller BB; Zhou H; Wang Y; Xu Z; Cai L
Diabetes; 2017 Feb; 66(2):529-542. PubMed ID: 27903744
[TBL] [Abstract][Full Text] [Related]
25. Proteasome Activators, PA28
Yadranji Aghdam S; Mahmoudpour A
Int J Nephrol; 2016; 2016():3846573. PubMed ID: 27830089
[TBL] [Abstract][Full Text] [Related]
26. Stabilization of endogenous Nrf2 by minocycline protects against Nlrp3-inflammasome induced diabetic nephropathy.
Shahzad K; Bock F; Al-Dabet MM; Gadi I; Nazir S; Wang H; Kohli S; Ranjan S; Mertens PR; Nawroth PP; Isermann B
Sci Rep; 2016 Oct; 6():34228. PubMed ID: 27721446
[TBL] [Abstract][Full Text] [Related]
27. Dietary flaxseed oil and fish oil ameliorates renal oxidative stress, protein glycation, and inflammation in streptozotocin-nicotinamide-induced diabetic rats.
Jangale NM; Devarshi PP; Bansode SB; Kulkarni MJ; Harsulkar AM
J Physiol Biochem; 2016 Jun; 72(2):327-36. PubMed ID: 27048415
[TBL] [Abstract][Full Text] [Related]
28. Twenty years after ACEIs and ARBs: emerging treatment strategies for diabetic nephropathy.
Johnson SA; Spurney RF
Am J Physiol Renal Physiol; 2015 Nov; 309(10):F807-20. PubMed ID: 26336162
[TBL] [Abstract][Full Text] [Related]
29. Apelin promotes diabetic nephropathy by inducing podocyte dysfunction via inhibiting proteasome activities.
Guo C; Liu Y; Zhao W; Wei S; Zhang X; Wang W; Zeng X
J Cell Mol Med; 2015 Sep; 19(9):2273-85. PubMed ID: 26103809
[TBL] [Abstract][Full Text] [Related]
30. Alteration of serum lipid profile, SRB1 loss, and impaired Nrf2 activation in CDKL5 disorder.
Pecorelli A; Belmonte G; Meloni I; Cervellati F; Gardi C; Sticozzi C; De Felice C; Signorini C; Cortelazzo A; Leoncini S; Ciccoli L; Renieri A; Jay Forman H; Hayek J; Valacchi G
Free Radic Biol Med; 2015 Sep; 86():156-65. PubMed ID: 26006105
[TBL] [Abstract][Full Text] [Related]
31. Diabetic cardiomyopathy and its mechanisms: Role of oxidative stress and damage.
Liu Q; Wang S; Cai L
J Diabetes Investig; 2014 Nov; 5(6):623-34. PubMed ID: 25422760
[TBL] [Abstract][Full Text] [Related]
32. Diabetic cardiomyopathy and its prevention by nrf2: current status.
Chen J; Zhang Z; Cai L
Diabetes Metab J; 2014 Oct; 38(5):337-45. PubMed ID: 25349820
[TBL] [Abstract][Full Text] [Related]
33. Effect of redox modulating NRF2 activators on chronic kidney disease.
Choi BH; Kang KS; Kwak MK
Molecules; 2014 Aug; 19(8):12727-59. PubMed ID: 25140450
[TBL] [Abstract][Full Text] [Related]
34. The proteasome inhibitor, MG132, attenuates diabetic nephropathy by inhibiting SnoN degradation in vivo and in vitro.
Huang W; Yang C; Nan Q; Gao C; Feng H; Gou F; Chen G; Zhang Z; Yan P; Peng J; Xu Y
Biomed Res Int; 2014; 2014():684765. PubMed ID: 25003128
[TBL] [Abstract][Full Text] [Related]
35. The role of ubiquitination and sumoylation in diabetic nephropathy.
Gao C; Huang W; Kanasaki K; Xu Y
Biomed Res Int; 2014; 2014():160692. PubMed ID: 24991536
[TBL] [Abstract][Full Text] [Related]
36. Zinc is essential for the transcription function of Nrf2 in human renal tubule cells in vitro and mouse kidney in vivo under the diabetic condition.
Li B; Cui W; Tan Y; Luo P; Chen Q; Zhang C; Qu W; Miao L; Cai L
J Cell Mol Med; 2014 May; 18(5):895-906. PubMed ID: 24597671
[TBL] [Abstract][Full Text] [Related]
37. Combating oxidative stress in diabetic complications with Nrf2 activators: how much is too much?
Tan SM; de Haan JB
Redox Rep; 2014 May; 19(3):107-17. PubMed ID: 24559141
[TBL] [Abstract][Full Text] [Related]
38. MG132 ameliorates kidney lesions by inhibiting the degradation of Smad7 in streptozotocin-induced diabetic nephropathy.
Gao C; Aqie K; Zhu J; Chen G; Xu L; Jiang L; Xu Y
J Diabetes Res; 2014; 2014():918396. PubMed ID: 24511554
[TBL] [Abstract][Full Text] [Related]
39. The ubiquitin-proteasome system and microvascular complications of diabetes.
Aghdam SY; Sheibani N
J Ophthalmic Vis Res; 2013 Jul; 8(3):244-56. PubMed ID: 24349668
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic effect of MG132 on the aortic oxidative damage and inflammatory response in OVE26 type 1 diabetic mice.
Miao X; Cui W; Sun W; Xin Y; Wang B; Tan Y; Cai L; Miao L; Fu Y; Su G; Wang Y
Oxid Med Cell Longev; 2013; 2013():879516. PubMed ID: 23589759
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
